Atlas Venture related stories
All articles and analysis
Fagnan to join Atlas as partnerAtlas Venture, the international early-stage venture capital investor, has announced that Jeff Fagnan will join its Waltham, Massachusetts office as a partner in August.
- Activa Capital buys pharma business
French mid-market private equity firm Activa Capital has acquired a majority stake in Delpharm, a pharmaceutical contract manufacturing outsourcing (CMO) firm.
- Former Sprout telecom head joins VantagePoint
Stephen Diamond leaves CSFB’s venture capital affiliate amidst the firm’s restructuring and fund downsizing.
- Deal round-up 18/11/03
Apax leads £25m series C round; Quester launches top-up for VCT5; Nordic funds back T-cellic B-round; Atlas, Gilde back merger with $7.5m investment;
- Deal round-up 26/11/03
Global Life Science Ventures leads $13m biotech round; VCs back French semiconductor company; UK Web filtering firms lands £7.3m round; DVC leads $8.5m Klotz Digital investment; NBG exits Bulgarian DIY chain;
- Deal round-up 9/12/03
Apax leads £15m Nexagent round; DVC, Motorola back UK software provider; Giza leads Cellectivity round; VCs back $15m CoreOptics investment
- Deal round-up 10/11/03
Atlas, Pond lead UK software second round; AMJPE backs Scottish furnishings business; SMAC leads SVOX second round; Catella buys Babcock unit; NBGI takes Wraith stake; Existing investors back Elata
- Deal round-up 06/10/03
Sovereign backs funeral buyout; Scottish Equity Partners leads BioVex round; Accent takes Cefar stake; Atlas leads Arrow Therapeutics financing; ING, Capricorn back TiGenix; Matrix leads Recite investment; Benchmark Capital funds Yoox; Apax backs $11m Iris round;
- Deal round-up 16/07/03
Benchmark, Atlas back Shell spin-off; Polytechnos, ING back Belgian genomics business; JPMorgan, Merlin lead £8m Piramed round, Gimv leads Elixent second round
- Deal round-up 15/09/03
LDC exits Spearhead investment; MTI funds VegaStream MBO; Sofinnova invests in Varioptic; BTG, Quester co-lead Xention round; Investcorp provides E12.1m for Utimaco; Benchmark Capital, Index Ventures back E3m round; Atlas, LCF lead U3 Pharma second round